PRIDE. Assessment of the Efficacy, Adherence and Tolerability of the Single Pill Combination Bisoprolol/Perindopril
N/A
Completed
NCT04656847
| Condition | Coronary Artery Disease, Myocardial Infarction, Arterial Hypertension |
|---|
| Phase | N/A |
|---|
| Sponsor | Servier Russia |
|---|
| Status | Completed |
|---|
| Enrollment | 504 participants |
|---|
| Interventions | in daily everyday routine practice |
|---|
| Start date | Mar 1, 2021 |
|---|
| Completion date | Oct 5, 2021 |
|---|
| Results posted | Nov 1, 2024 |
|---|
Summary
This non-interventional, ambispective study was aimed at evaluating the effectiveness, safety, and tolerability of bisoprolol and perindopril SPC in previous myocardial infarction patients with HTN and CAD treated with the drug for 12 weeks in the daily clinical practice. SPC will be used according to the approved instruction for medical use of the medicine. This is a multi-centre, observational, incomparative, ambispective study, which will retrospectively and prospectively collect clinical variables and socio-demographic data from medical records of patients with HTN and previous MI initiated with bisoprolol/perindopril SPC in real life settings.
Antihypertensive Effectiveness (SBP and DBP) of Bisoprolol/Perindopril SPC in CAD Patients With Previous MI and HTN at Week 12 of Treatment Compared With Baseline
3 months · mm Hg
| CAD Patients With Previous MI and HTN | -24.92 ± 16.43 mm Hg |
|---|
| CAD Patients With Previous MI and HTN | -12.21 ± 11.03 mm Hg |
|---|
Open in BENITIONS
View on ClinicalTrials.gov
All trials
This page summarises publicly available data from ClinicalTrials.gov. It is not medical advice and not investment advice. Always consult a qualified healthcare professional.